Early Onset Neonatal Sepsis Pathogens in Malaysian Hospitals: Determining Empiric Antibiotic

Authors: Nazedah Ain Ibrahim, Mohamed Mansor Manan

Abstract:

Information regarding early onset neonatal sepsis (EONS) pathogens may vary between regions. Global perspectives showed Group B Streptococcal (GBS) as the most common causative pathogens, but the widespread use of intrapartum antibiotics has changed the pathogens pattern towards gram negative microorganisms, especially E. coli. Objective of this study is to describe the pathogens isolated, to assess current treatment and risk of EONS. Records of 899 neonates born in three General Hospitals between 2009 until 2012 were retrospectively reviewed. Proven was found in 22 (3%) neonates. The majority was isolated with gram positive organisms, 17 (2.3%). All grams positive and most gram negative organisms showed sensitivity to the tested antibiotics. Only two rare gram negative organisms showed total resistant. Male was possible risk of proven EONS. Although proven EONS remains uncommon in Malaysia, nonetheless, the effect of intrapartum antibiotics still required continuous surveillance.

Keywords: Early onset neonatal sepsis, neonates, pathogens, gram positive, gram negative.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1096189

References:

[1] L. A-B Ann. et al., "Neonatal Sepsis,” Retrieved September 3, 2011 from http://emedicine.medscape.com/article/978352-overview, 2011.
[2] S. Vergnano, M. Sharland, P. Kazembe,. and C. P. T. Mwansambo, "Heath Neonatal sepsis: an international perspective,” Archives of Disease in Childhood. Fetal Neonatal, Edition, 2005, 90, F220–F224.
[3] W.E. Benitz, J.B. Gould, and M.L. Druzin, "Antimicrobial prevention of early-onset Group B Streptococcal Sepsis: Estimates of risk reduction based on a critical literature review” Journal of the American Academy of Pediatrics, 1999, 103, e78.
[4] S. Kenyon, M. Boulvain and J. Neilson, "Antibiotics for preterm rupture of membranes (Review),” Cochrane Database of Systematic Review, 2007, 4, CD001058.
[5] T. Siriwachirachai, ,U.S. Sangkomkamhang, P. Lumbiganon, and M. Laopaiboon, "Antibiotics for meconium-stained amniotic fluid in labour for preventing maternal and neonatal infections (Review),” Cochrane Database System Review, 2010, 12, CD007772.
[6] C. H. Raynes-Greenow, C. L Roberts, J. C. Bell, B. Peat, G. L. Gilbert and S. Parker, " Antibiotics for ureaplasma in the vagina in pregnancy (Review),” Cochrane Database of Systematic Review, 2011, 9, CD003767.
[7] J.R. Verani, L. McGee and S.J. Schrag, "Prevention of perinatal group B streptococcal disease-revised guigelines from CDC, 2010. Division of Bacterial Diseases, national Center for Immunization and Respiratory Diseases, Center for Disease Control and Prevention (CDC),” MMWR Recomm Rep 2010, 59 (RR-10):1-36.
[8] ACOG, Committee opinion, "Prevention of early-onset group B streptococcal disease in newborns,” The American College of Obstetricians and Gynecologists, 2011,485.
[9] E.I. Mtitimila and R.W. Cooke, "Antibiotic regimens for suspected early neonatal sepsis,” Cochrane Database of Systematic Review, 2004, CD004495.
[10] R.H. Clark, B.T. Bloom, A.R. Spitzer and D.R. Gerstmann, "Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death,” Journal of the American Academy of Pediatrics, 2006, 117, 67-74.
[11] T. Metsvaht, M-L. Ilmoja, Ü. Parm, L. Maipuu, M. Merila and I. Lutsar, "Comparison of ampicillin plus gentamicin vs. penicillin plus gentamicin in empiric treatment of neonates at risk of early onset sepsis,” Acta Paediatrica , 2010, 99, 665-672.
[12] J. S. Schrag, J. L. Hadler, K.E. Arnold, P. Martell-Cleary, A. Reingold, and A. Schuchat, " Risk factors for invasive, early onset Escherichia coli infections in the era of widespread intrapartum antibiotic use,” Journal of the American Academy of Pediatrics, 2006, 118, 570-576.
[13] M.J. Bizzarro, L-M. Dembry, R.S. Baltimore and P.G. Gallagher, "Changing patterns in neonatal Escherichia coli sepsis and the ampicillin resistance in the era of intrapartum antibiotic prophylaxis,” Journal of the American Academy of Pediatrics, 2008, 121, 689-696.
[14] M.P. Weinstein, "Blood culture contamination: Persisting problems and partial progress,” Journal of Clinical Microbiology, 2003, 41,6,2275- 2278.
[15] J.S. Gerdes, "Diagnosis and management of bacterial infections in the neonate,” Journal of Pediatric Clinical of Noth America, 2004, 51, 939- 959.
[16] R.Y. Bhat, and L.P. Baby, "Early onset of neonatal sepsis: analysis the risk factors and the bacterial isolated by using the BacT alert system,” Journal of Clinical and Diagnostic Research, 2011, 5,7,1385-1388.
[17] WHO, 17th Expert Committee on the Selection and Use of Essential Medicines, "Review of the efficacy and safety of procaine benzylpenicillin in neonates,” 2009.
[18] B.J. Stoll, N.I. Hansen, R.D. Higgins, A.A. Fanaroff, S. Duara, R. Goldberg, A. Laptook, M. Walsh, W. Oh and E. Hale, "Very low birth weight preterm infants with early onset neonatal sepsis: The predominance of gram negative infections continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002-2003,” The Pediatric Infection Disease Journal, 2005, 24, 635-639.
[19] N.E. Glass, J. Sculkin, S. Chamany, L.E. Riley, A. Schuchat and S. Schrag, "Opportunities to reduce overuse of antibiotics for perinatal group B streptococcal disease prevention and management of preterm premature rupture of membranes,” Infectious Diseases in Obstetrics and Gynecology, 2005, 13,1,5-10.
[20] S. Schrag, R. Gorwitz, K. Fultz-Butts, and A. Scuchat, "Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC,” MMWR Recommendations and Reports, 2002, 51(RR-11):1-22.
[21] M.R. Moore, S.J. Schrag and A. Schuchat, "Effects of intrapartum antimicrobial prophylaxis for prevention of group B streptococcal disease on the incidence and ecology of early onset neonatal sepsis,” The Lancet Infectious Diseases, 2003, 3,201-213.
[22] B.J. Stoll, N. Hansen, A. Fanaoff, L.L. Wright, W.A. Carlo, R.A. Ehrenkranz, J.A. Lemons, E.F. Donovan, A.R. Stark, J.E. Tayson, W. Oh, C. R. Bauer, S.B. Korones, S. Shankaran, A.R. Laptook, D.K. Stevenson, L-A. Papile and K. Poole, "Changes in pathogens causing Early-Onset Sepsis in very-low-birth-weight infants,” New England Journal of Medicine, 2002, 347, 240-247.
[23] P. Kuhn, C. Dheu, B. C olender, D. Chognot, L. Keller, H. Demil, L. Donato, B. Langer, J. Messer and D. Astruc, "Incidence and distribution of pathogens in early onset neonatal sepsis in the era of antenatal antibiotics,” Paediatric and Perinatal Epidemiology, 2010, 24,479-487.
[24] C.H. Tsai, Y.Y. Chen, K.G. Wang, C.Y. Chen and C.P. Chen, "Characteristics of early onset sepsis caused by Escherichia coli,” Taiwanese Journal of Obstetrics & Gynecology, 2011 51,26-30.
[25] R. Ghotaslou, Z. Ghorashi and M-R. Nahaei, "Klebsiella pneumonia in neonatal sepsis: A 3 year study in the Pediatric Hospital of Tabriz, Iran, 2007, 60,126-128.
[26] J.M. Andrews, "Determination of minimum inhibitory concentrations,” Journal of Antimicrobial Chemotherapy, 2001, 48,S1,5-16.
[27] C.M. Muvunyi, F. Masaisa, C. Bayingana, L. Mutesa, A. Musemakweri, G. Muhirwa and G. (W.) Claeys, "Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: Need for new antimicrobial guidelines,” American Journal of Tropical Medicine and Hygiene, 2011, 84,6,923- 928.
[28] H. Gazi, S. Kurutepe, S. Surucuoglu, A. Teker, and B. Ozbakkaloglu, "Antimicrobial susceptibility of bacterial pathogens in the oropharynx of healthy school children in Turkey,” Indian Journal of Medical Research, 2004, 120,489-494.
[29] A. Nerurkar, P. Solanky and S.S. Naik, "Bacterial pathogens in urinary tract infection and antibiotic susceptibility pattern,” Journal of Pharmaceutical and Biomedical Sciences, 2012, 21,21,1-3.
[30] M. .Radji, Siti Fauziah and N. Aribinuko, "Antibiotic sensitivity pattern of bacterial pathogens in the intensive care unit of Fatmawati Hospital, Indonesia,” Asian Pacific Journal of Tropical Biomedicine, 2011, 1,1,39-42.
[31] I. Shaifali, U. Gupta, S.E. Mahmood and J. Ahmed, "Antibiotic susceptibility patterns of urinary pathogens in female outpatients,” North American Journal of Medical Sciences, 2012, 4,4,163-169.
[32] E. Saez-Lopez, E. Guiral and S.M. Soto, "Neonatal sepsis by bacteria: A big problem for children,” Clinical Microbiology, 2013, 2,6,1000125.
[33] National Antibiotic Guideline. Malaysia: Ministry of Health, 2008. Page 181.
[34] A.I. Nazedah, M.M. Mohamed, and A.A. Noorizan, "The Effectiveness of empiric antibiotic therapy in the prevention of early onset sepsis,” International Journal of Current Research, 2014, 4,6258-6265.